MYC and neoplasm: Specifically, GSEA analysis revealed significant activation of MYC and mTORC1 signaling pathways in the high-risk group, which are known to reshape the tumor immune microenvironment, suppress T cell function, and promote myeloid-derived suppressor cell accumulation (Dhanasekaran et al., 2022; Kim et al., 2017).